Andrew N. Billin
0000-0001-7752-0934
Publication & Citation Trends
Publications
0 total
Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
Cited by 0
Semantic Scholar
Filgotinib treatment modulates frequency and gene expression of circulating immune cell subsets in ulcerative colitis
Cited by 0
Semantic Scholar
Comprehensive characterization of granular fibrotic and cellular features in liver tissue enabled by deep learning models
Cited by 0
Semantic Scholar
Su1926: LEVERAGING ARTIFICIAL INTELLIGENCE FOR ENHANCED HISTOLOGICAL SCORING IN ULCERATIVE COLITIS: A COMPARISION WITH HUMAN PATHOLOGISTS
Cited by 0
Semantic Scholar
Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease
Cited by 2
Semantic Scholar
The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease.
Cited by 3
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(33)
Peroxisome Proliferator-Activated Receptors
(23)
Liver Diseases and Immunity
(17)
Adipose Tissue and Metabolism
(11)
Muscle Physiology and Disorders
(10)
Affiliations
Research Triangle Park Foundation
University of California, Santa Barbara
RTI International
University of Toronto
GlaxoSmithKline (United Kingdom)